The Good News About AMD Prevention and Early Intervention
AMD severity is measured on a spectrum, and the sooner doctors, patients, and caregivers are aware of its presence, the sooner everyone can work together to protect against it.
By
Pamela Lowe, OD
March 2, 2026
Clinical Scorecard: The Good News About AMD Prevention and Early Intervention
At a Glance
Category Detail
Condition Age-related macular degeneration (AMD) Key Mechanisms Early diagnosis and management of modifiable risk factors can slow disease progression. Target Population Adults aged 40 years and over, particularly those with risk factors. Care Setting Primary eye care and specialty low vision care.
Key Highlights
78% of AMD patients present with irreversible vision loss at diagnosis. Smoking is the greatest modifiable risk factor for AMD. Nutritional supplements can slow AMD progression in early-stage patients. Dark adaptation testing can detect AMD up to 3 years earlier than traditional methods. Regular comprehensive eye exams are crucial for early detection. Guideline-Based Recommendations
Diagnosis
Utilize dark adaptation testing to identify early AMD. Measure macular pigment optical density (MPOD) for dietary recommendations. Management
Implement lifestyle modifications including smoking cessation and a Mediterranean diet. Prescribe carotenoid nutraceuticals for patients at risk. Monitoring & Follow-up
Track progression through regular eye examinations and MPOD measurements. Monitor dark adaptation times as an early biomarker. Risks
Age, family history, and ethnicity (White) are nonmodifiable risk factors. Delayed intervention can lead to irreversible vision loss. Patient & Prescribing Data
Adults aged 40 years and over, particularly those with early-stage AMD.
Nutritional supplements and lifestyle changes can significantly impact disease progression.
Clinical Best Practices
Encourage yearly comprehensive eye exams for early detection. Educate patients on the importance of a healthy diet rich in antioxidants. Utilize technology for early diagnosis and monitoring of AMD. Related Resources & Content
